US 11,767,366 B1
Pseudotyped viral particles, compositions comprising the same, and uses thereof
Ronnie M. Russell, Philadelphia, PA (US); and Philip R. Johnson, Philadelphia, PA (US)
Assigned to INTERIUS BIOTHERAPEUTICS, INC., Philadelphia, PA (US)
Filed by INTERIUS BIOTHERAPEUTICS, INC., Philadelphia, PA (US)
Filed on Dec. 15, 2022, as Appl. No. 18/66,420.
Claims priority of provisional application 63/267,039, filed on Jan. 21, 2022.
Claims priority of provisional application 63/266,044, filed on Dec. 27, 2021.
Claims priority of provisional application 63/289,977, filed on Dec. 15, 2021.
Claims priority of provisional application 63/289,888, filed on Dec. 15, 2021.
Int. Cl. C12N 15/86 (2006.01); C07K 16/28 (2006.01); C12N 15/113 (2010.01)
CPC C07K 16/2896 (2013.01) [C12N 15/113 (2013.01); C12N 15/86 (2013.01); C12N 2740/15043 (2013.01)] 30 Claims
 
1. A polypeptide comprising an amino acid sequence that is at least 95% identical to the amino acid sequence of SEQ ID NO: 2 and a I182E mutation as compared to SEQ ID NO: 2.